03 Mar 2023 15:44 CET

Issuer

Aqua Bio Technology ASA

3.3.2023 15:44:45 CET | Aqua Bio Technology ASA | Non-regulatory press releases

ABT has been granted a US patent for use of Chaga in cosmetic formulation. The
Chaga mushroom grows on birch trees throughout the northern hemisphere. The
extract from Chagas mushroom has shown good results on wrinkles and general skin
improvement. The extract from Chagas mushroom can be beneficial for anyone
suffering from skin conditions such as acne, allergic reactions, rashes,
dermatitis, psoriasis, rosacea and eczema. The US patent secures ABT's use of
this ingredient in existing and future cosmetic products and prohibits other
players to use this ingredient without a specific license from ABT.

Co-location:

From 1 March 2023, Hofseth Biocare ASA, Cosmed Beauty AS and Aqua Bio Technology
ASA are co-located in Bygdøy Alle 3 in Oslo. The co-location will lead to
increased synergies between the companies that all have the same main
shareholder.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/2156/2900/Download%20announcement
%20as%20PDF.pdf


584269_en_Download announcement as PDF.pdf

Source

Aqua Bio Technology ASA

Provider

Oslo Børs Newspoint

Company Name

AQUA BIO TECHNOLOGY

ISIN

NO0010307135

Symbol

ABTEC

Market

Euronext Expand